Section Arrow
Quote
ATRC.NASDAQ
- AtriCure
Quotes are at least 15-min delayed:2025/07/07 00:48 EDT
Last
 31.76
+0.37 (+1.18%)
Day High 
32.025 
Prev. Close
31.39 
1-M High
35.33 
Volume 
166.07K 
Bid
13.33
Ask
40.71
Day Low
31.33 
Open
31.7 
1-M Low
30.85 
Market Cap 
1.55B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 32.14 
20-SMA 32.78 
50-SMA 32.54 
52-W High 43.11 
52-W Low 20.2 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.81/-0.33
Enterprise Value
1.63B
Balance Sheet
Book Value Per Share
9.18
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
465.31M
Operating Revenue Per Share
7.69
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AVTRAvantor13.88-0.01-0.07%13.36PE
MBOTMicrobot Medical2.6+0.1+4.00%-- 
ALCAlcon87.78-1.52-1.70%39.69PE
XRAYDENTSPLY SIRONA16.67+0.1+0.60%-- 
COOCooper Companies (The)73.3+0.28+0.38%35.28PE
Quotes are at least 15-min delayed：2025/07/07 00:48 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct salesforce and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.